GHRELIN-MEDIATED PROMOTION OF PROSTATE GROWTH AND PROSTATE SMOOTH MUSCLE CONTRACTION: EVIDENCE FROM FUNCTIONAL, IN VIVO, AND GENOMIC APPROACHES

Xiaolong Wang,Yiming Wang,Christian Gratzke,Bingsheng Li,Qingfeng Yu,Frank Strittmatter,Christian G. Stief,Chunxiao Liu,Martin Hennenberg
DOI: https://doi.org/10.1016/s1569-9056(19)30189-7
2019-01-01
Abstract:cells cultured with rapamycin (Rap, autophagy activator) treatment for 3 days, the conditioned media was harvested and used to evaluate the proliferation of Prsc cells.Quantitative PCR was used to identify cytokines secreted by Prsc cells treated with rapamycin.RESULTS: 1.The expression of LC3 protein was overexpressed in early-progressed BPH patients than the other groups and it was positive correlation with a-smooth muscle actin and collagen I. 2. Autophagy inhibitor CQ could suppress the expression of a-smooth muscle actin and collagen I in Prsc cells via AKT and Erk signaling pathways.Furthermore, it promoted the expression of cleaved-PARP protein and p62. 3. The conditioned media (rapamycin to Prsc) could accelerate the proliferation of Prsc53 cell.4. CCL5, CXCL8, CXCL12, CXCL13, IL-5, IL-17a and FGF6 were increased in Prsc53 cell after treated with rapamycin for 24 hours.CONCLUSIONS: Autophagy may be as an important effector in the progression of benign prostatic hyperplasia through stimulating myofibroblast phenotype, proliferation and its apoptosis.
What problem does this paper attempt to address?